To verify the immunosuppressive effect of Tregs on the infiltration of adoptive CTLs into the tumor areas, CTX (150 mg kg−1) was used to specifically abrogate Tregs on the fourth day after the implantation of CFP-B16 tumor cells. Here, CFP is linked to neoplasm.